Summary of RAPTOR PHARMACEUTICAL CORP

Item 8.01 Other Events.
On November 5, 2012, Raptor Pharmaceutical Corp., a Delaware corporation (the "Company"), issued a press release announcing that Craig B. Langman, M.D., Head of Kidney Diseases, and the Isaac A. Abt, M.D., Professor of Kidney Diseases and Tenured Professor of Pediatrics, Northwestern University Feinberg School of Medicine, presented on Saturday, November 3rd a "Late Breaking" poster entitled "Extended Treatment with RP 103 in Patients with Nephropathic Cystinosis" at Kidney Week 2012, presenting data from the Company's RP103 (cysteamine bitartrate delayed-release) extension study.
A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item 8.01. Item 9.01 Financial Statements and Exhibits

(d)      Exhibits.
                            Filed
Exhibit                     Here                 Incorporated by Reference
  No.   Exhibit Description with   Form  File No.  Exhibit Filing Date      Filed By
 99.1   Press release         X
        issued by the
        Company dated as of
        November 5, 2012